Stay updated with breaking news from Highly Selective. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
13.06.2022 - Leuven, BELGIUM, Boston, MA, US – JUNE 13, 2022 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today ...
Investegate announcements from Oxurion NV, Oxurion Announces Two Presentations at The Macula Society 45th Annual Meeting
Investegate announcements from Oxurion NV, Oxurion Announces Two Upcoming Presentations at The Macula Society 45th Annual Meeting
Leuven, BELGIUM, Boston, MA, US - JUNE 3, 2022 - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies,
Press release content from Globe Newswire. The AP news staff was not involved in its creation.